Cat. No.: X24-08-YM066
Topoisomerase inhibitor, Edotecarin, Purity ≥98%
Synonym: 174402-32-5; J 107088; PF 804950; 13-(1,3-Dihydroxypropan-2-ylamino)-6,20-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione
- CAS Number: 174402-32-5
- Compound CID: 9808998
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Properties
Description
Edotecarin is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase. It targets the protein kinase C and topoisomerase I.
Molecular Formula
C29H28N4O11
Targets
Protein kinase C: 160 μM (IC50); Topoisomerase I: 50 nM (IC50)
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Edotecarin is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of solid tumors.
Related Products
- Topoisomerase inhibitor, ABT-492, Purity ≥98%
- Topoisomerase inhibitor, Amonafide, Purity ≥98%
- Topoisomerase inhibitor, Camptothecin, Purity ≥98%
- Topoisomerase inhibitor, Gatifloxacin, Purity ≥98%
- Topoisomerase inhibitor, Idarubicin HCl, Purity ≥98%
- Topoisomerase inhibitor, Irinotecan, Purity ≥98%
